Analgesics in Egypt

  • ID: 227069
  • Report
  • Region: Egypt
  • 18 pages
  • Euromonitor International
1 of 4
Due to the diversity of brands and availability of a range of prices in all pharmacies, analgesics remained dynamic in Egypt in 2017. Egyptians tend to self-medicate, especially for mild pain, or simply consult a pharmacist, rather than seek a doctor’s advice if an analgesic is needed. Retail current value sales posted strong growth, due to the price increases decided by the Ministry of Health in 2016 and 2017. All analgesics available in the market are sold without prescription.

The Analgesics in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
2 of 4
ANALGESICS IN EGYPT

List of Contents and Tables
  • Headlines
  • Prospects
  • Analgesics Leads Consumer Health in 2017
  • Paediatric Analgesics Sales Remain Small Despite the Large Child Population
  • Pharmacists Monopolises Distribution
  • Competitive Landscape
  • GlaxoSmithKline Egypt Remains the Leading Player
  • the Rest of the Competitive Landscape Is Fragmented
  • Marketing Remains A Challenge for Companies
  • Category Data
  • Table 1 Sales of Analgesics by Category: Value 2012-2017
  • Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  • Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  • Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  • Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  • Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  • Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
  • Executive Summary
  • High Unit Price Increases in 2017
  • Healthy Retail Volume and Value Growth in 2017 Despite the Economic Turmoil
  • GlaxoSmithKline Egypt Leads Consumer Health in Egypt
  • Pharmacies Dominates Consumer Health Distribution in 2017
  • Healthy Growth Is Expected Over the Forecast Period
  • Market Indicators
  • Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  • Table 9 Life Expectancy at Birth 2012-2017
  • Market Data
  • Table 10 Sales of Consumer Health by Category: Value 2012-2017
  • Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  • Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  • Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  • Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
  • Appendix
  • OTC Registration and Classification
  • Vitamins and Dietary Supplements Registration and Classification
  • Self-medication/self-care and Preventive Medicine
  • Switches
  • Definitions
  • Sources
  • Summary 1 Research Sources
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
CH06anEG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll